Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Read More…
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples
Phone801-345-1000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.68 billion
Profitability
Miscellaneous
Employees4,900
Next Earnings Date11/5/2019 (Confirmed)
OptionableOptionable
Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions
What is Nu Skin Enterprises' stock symbol?
Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."
How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?
Nu Skin Enterprises declared a quarterly dividend on Tuesday, August 6th. Shareholders of record on Friday, August 30th will be given a dividend of $0.37 per share on Wednesday, September 11th. This represents a $1.48 dividend on an annualized basis and a yield of 3.51%. The ex-dividend date of this dividend is Thursday, August 29th. View Nu Skin Enterprises' Dividend History.
How were Nu Skin Enterprises' earnings last quarter?
Nu Skin Enterprises, Inc. (NYSE:NUS) announced its earnings results on Tuesday, August, 6th. The company reported $0.83 earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of $0.83. The firm earned $623.50 million during the quarter, compared to analyst estimates of $622.32 million. Nu Skin Enterprises had a net margin of 4.79% and a return on equity of 24.73%. The business's revenue was down 11.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.95 EPS. View Nu Skin Enterprises' Earnings History.
When is Nu Skin Enterprises' next earnings date?
How can I listen to Nu Skin Enterprises' earnings call?
Nu Skin Enterprises will be holding an earnings conference call on Tuesday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Nu Skin Enterprises issued on next quarter's earnings?
Nu Skin Enterprises updated its FY19 earnings guidance on Tuesday, August, 6th. The company provided earnings per share (EPS) guidance of $3.20-$3.35 for the period, compared to the Thomson Reuters consensus estimate of $3.30. The company issued revenue guidance of $2.48-$2.52 billion, compared to the consensus revenue estimate of $2.51 billion.
What price target have analysts set for NUS?
8 analysts have issued 12 month target prices for Nu Skin Enterprises' stock. Their predictions range from $39.00 to $70.00. On average, they anticipate Nu Skin Enterprises' stock price to reach $50.71 in the next year. This suggests a possible upside of 20.4% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.
What is the consensus analysts' recommendation for Nu Skin Enterprises?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 2 sell ratings, 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nu Skin Enterprises.
What are Wall Street analysts saying about Nu Skin Enterprises stock?
Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
- 1. Pivotal Research analysts commented, "We suspect that NUS management has taken an axe to the outlook to avoid having to cut again." (8/7/2019)
- 2. According to Zacks Investment Research, "Nu Skin, which has outdone the industry in the past month, has been steadily gaining from solid performance across most regional units and sustained growth in customer count. These upsides and enhanced margins fueled first-quarter 2019 results, wherein top and bottom lines grew year over year and surpassed estimates. Further, the company’s focus on expanding global beauty device systems and optimizing the Velocity program bodes well. This is reflected in management’s outlook for 2019. However, the company issued a soft view for the second quarter, which is likely to be hurt by tough year-over-year comparisons related to LumiSpa. Moreover, currency headwinds are expected to persist, and hurt sales growth by 4-5% and 2-3% in the second quarter and 2019, respectively. Competition from cheaper alternatives is certainly a threat as well." (5/3/2019)
Has Nu Skin Enterprises been receiving favorable news coverage?
News coverage about NUS stock has been trending negative on Tuesday, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nu Skin Enterprises earned a news impact score of -2.8 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Nu Skin Enterprises.
Are investors shorting Nu Skin Enterprises?
Nu Skin Enterprises saw a increase in short interest in September. As of September 30th, there was short interest totalling 1,200,000 shares, an increase of 5.3% from the August 30th total of 1,140,000 shares. Based on an average daily trading volume, of 643,400 shares, the short-interest ratio is currently 1.9 days. Currently, 2.3% of the company's shares are short sold. View Nu Skin Enterprises' Current Options Chain.
Who are some of Nu Skin Enterprises' key competitors?
What other stocks do shareholders of Nu Skin Enterprises own?
Who are Nu Skin Enterprises' key executives?
Nu Skin Enterprises' management team includes the folowing people:
- Mr. Steven J. Lund, Exec. Chairman (Age 66)
- Mr. Ritch N. Wood, CEO & Director (Age 53)
- Mr. Ryan S. Napierski, Pres (Age 45)
- Mr. Mark H. Lawrence, Exec. VP & CFO (Age 49)
- Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 66)
Who are Nu Skin Enterprises' major shareholders?
Nu Skin Enterprises' stock is owned by a number of of retail and institutional investors. Top institutional investors include Pacer Advisors Inc. (0.04%), Cerebellum GP LLC (0.02%), State of Alaska Department of Revenue (0.02%) and Cerebellum GP LLC (0.00%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Edwina D Woodbury, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.
Which institutional investors are selling Nu Skin Enterprises stock?
Which institutional investors are buying Nu Skin Enterprises stock?
How do I buy shares of Nu Skin Enterprises?
Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Nu Skin Enterprises' stock price today?
One share of NUS stock can currently be purchased for approximately $42.12.
How big of a company is Nu Skin Enterprises?
Nu Skin Enterprises has a market capitalization of $2.34 billion and generates $2.68 billion in revenue each year. The company earns $121.88 million in net income (profit) each year or $3.52 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe.View Additional Information About Nu Skin Enterprises.
What is Nu Skin Enterprises' official website?
How can I contact Nu Skin Enterprises?
Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]
MarketBeat Community Rating for Nu Skin Enterprises (NYSE NUS)
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
